# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-19-047387
Filing Date
2019-10-04
Accepted
2019-10-04 16:46:08
Documents
4
Period of Report
2019-12-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | tv530595_pre14a.htm | PRE 14A | 169008
2 | GRAPHIC | tv530595_img001.jpg | GRAPHIC | 5865
3 | GRAPHIC | tv530595_proxy-img01.jpg | GRAPHIC | 241948
4 | GRAPHIC | tv530595_proxy-img02.jpg | GRAPHIC | 320119
| Complete submission text file | 0001144204-19-047387.txt |  | 952837

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33357 | Film No.: 191139008
SIC: 2836 Biological Products, (No Diagnostic Substances)